Skip to main content

Asthma resources for healthcare professionals

National Capabilities Framework

Please see link to the Health Education England's National Capabilities Framework for Professionals who care for children and young people with asthma: 

National-Capabilities-Framework.pdf

 

Maintenance and Reliever Therapy (MART) 

Maintenance and Reliever Therapy (MART) uses one combined inhaler for prevention and relief of asthma symptoms. It contains steroid and a fast acting long-acting beta agonist (LABA). Examples of inhalers which can be used in MART for over 12 years of age are Symbicort and DuoResp Spiromax.

Advantages of MART:

  • Airway inflammation is treated when the patient is symptomatic, as well as providing relief
  • Improves adherence with asthma medications
  • Reduces the likelihood of asthma attacks and hospital admission
  • As many MART inhalers are dry powder inhalers, it offers an inhaler with lower carbon emissions

MART may not be suitable for all patients, and they must be included in the decision to start MART as they must understand their asthma symptoms, when to use their reliever and when to seek help. Additionally, they must be able to use a dry powder device if this is chosen. 

MART action plans are available here: https://shop.asthmaandlung.org.uk/collections/new-shop-hcp/products/mart-asthma-action-plan

 
National Bundle of Care for Children & Young People with Asthma: 

https://www.england.nhs.uk/publication/national-bundle-of-care-for-children-and-young-people-with-asthma/

Clinical Digital Resource Collaborative - Beat Asthma+ Project 

https://cdrc.nhs.uk/resources/emis-resource-centre/emis-specialties/respiratory-overview/beatasthma-guide-for-emis/

 

ACUTE ASTHMA:
CHRONIC ASTHMA:
INHALERS
ALLERGY:
BREATHLESSNESS
SMOKING CESSATION: